Huntington National Bank Decreases Position in Teleflex Incorporated (TFX)

Huntington National Bank trimmed its position in shares of Teleflex Incorporated (NYSE:TFX) by 38.6% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,333 shares of the medical technology company’s stock after selling 838 shares during the period. Huntington National Bank’s holdings in Teleflex were worth $332,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. State Street Corp raised its holdings in shares of Teleflex by 1.8% during the 2nd quarter. State Street Corp now owns 1,399,922 shares of the medical technology company’s stock valued at $290,853,000 after buying an additional 25,401 shares in the last quarter. American Century Companies Inc. grew its position in Teleflex by 41.6% during the 3rd quarter. American Century Companies Inc. now owns 1,187,909 shares of the medical technology company’s stock worth $287,438,000 after acquiring an additional 348,829 shares during the last quarter. Koch Industries Inc. grew its position in Teleflex by 47,174.3% during the 2nd quarter. Koch Industries Inc. now owns 959,669 shares of the medical technology company’s stock worth $955,000 after acquiring an additional 957,639 shares during the last quarter. Principal Financial Group Inc. grew its position in Teleflex by 0.8% during the 3rd quarter. Principal Financial Group Inc. now owns 615,382 shares of the medical technology company’s stock worth $148,905,000 after acquiring an additional 4,984 shares during the last quarter. Finally, Frontier Capital Management Co. LLC grew its position in Teleflex by 1.3% during the 3rd quarter. Frontier Capital Management Co. LLC now owns 308,622 shares of the medical technology company’s stock worth $74,677,000 after acquiring an additional 4,077 shares during the last quarter. 88.86% of the stock is currently owned by institutional investors.

Several equities analysts recently issued reports on TFX shares. Morgan Stanley raised their price target on Teleflex from $274.00 to $290.00 and gave the stock an “equal weight” rating in a research report on Friday, November 3rd. Jefferies Group raised their price target on Teleflex from $270.00 to $295.00 and gave the stock a “buy” rating in a research report on Friday, November 3rd. Leerink Swann restated a “buy” rating and set a $321.00 price target (up from $307.00) on shares of Teleflex in a research report on Tuesday, January 30th. Deutsche Bank lowered Teleflex from a “buy” rating to a “hold” rating and set a $251.00 price target on the stock. in a research report on Tuesday, November 14th. Finally, Stephens restated a “buy” rating and set a $300.00 price target on shares of Teleflex in a research report on Thursday, January 18th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and six have given a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus price target of $283.89.

In other news, Director George Babich, Jr. sold 2,500 shares of Teleflex stock in a transaction that occurred on Tuesday, January 16th. The stock was sold at an average price of $263.38, for a total value of $658,450.00. Following the sale, the director now directly owns 10,583 shares in the company, valued at approximately $2,787,350.54. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Stephen K. M.D. Klasko sold 200 shares of Teleflex stock in a transaction that occurred on Friday, December 1st. The stock was sold at an average price of $265.32, for a total value of $53,064.00. Following the completion of the sale, the director now owns 8,080 shares in the company, valued at $2,143,785.60. The disclosure for this sale can be found here. Over the last quarter, insiders sold 7,600 shares of company stock worth $2,040,569. Corporate insiders own 2.39% of the company’s stock.

Shares of Teleflex Incorporated (TFX) opened at $252.75 on Friday. The firm has a market capitalization of $11,852.01, a P/E ratio of 46.12, a PEG ratio of 1.94 and a beta of 1.15. Teleflex Incorporated has a 1 year low of $172.09 and a 1 year high of $288.78. The company has a debt-to-equity ratio of 0.88, a current ratio of 4.72 and a quick ratio of 3.70.

TRADEMARK VIOLATION WARNING: This piece of content was originally reported by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this piece of content on another website, it was copied illegally and republished in violation of United States and international copyright & trademark law. The original version of this piece of content can be read at https://sportsperspectives.com/2018/02/10/huntington-national-bank-decreases-position-in-teleflex-incorporated-tfx.html.

Teleflex Profile

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX).

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply